Key result
Ciprofloxacin at 10 mg/kg significantly prolonged the QT interval (maximum change 11 ms) and monophasic action potential duration in halothane-anesthetized guinea pigs.
Why the study?
Does ciprofloxacin prolong ventricular repolarization in halothane-anesthetized guinea pigs?
Does ciprofloxacin prolong ventricular repolarization in halothane-anesthetized guinea pigs?
p-value: p=<0.05
Ciprofloxacin at supra-therapeutic doses exerts multi-ion channel-blocking actions, prolonging ventricular repolarization and delaying conduction in a guinea pig model, suggesting caution when using high-dose regimens in patients with heart disease.
May suggest caution with high-dose ciprofloxacin in cardiac patients; leaves open clinical translation from this guinea pig model.
The fluoroquinolone antibiotic ciprofloxacin has been reported to block delayed rectifier K(+) channels at much higher concentrations than those at which it exerts its bactericidal activity. In this study using the halothane-anesthetized guinea pig, we assessed whether ciprofloxacin has a proarrhythmic activity. Ciprofloxacin at a clinically relevant dose of 3 mg/kg, i.v. did not affect any electrocardiographic parameters. At 10 mg/kg, it prolonged the QT interval and the duration of the monophasic action potential of the ventricle under sinus rhythm and constant ventricular pacing (n = 6). The extents of its effects on the ventricular repolarization phase were comparable to those of another fluoroquinolone antibiotic moxifloxacin at a clinically relevant dose of 3 mg/kg (n = 6). Meanwhile, the PR interval and QRS width were also increased by ciprofloxacin at 10 mg/kg, suggesting that the drug inhibited cardiac K(+) channels as well as Na(+) and Ca(2+) channels in vivo. These results suggest that ciprofloxacin exerted a multi-ion channel-blocking action in the heart within the supra-therapeutic dose range. Therefore, careful observation may be necessary for patients with heart disease receiving a higher dose of ciprofloxacin in order to prevent the emergence of resistance.
No takes yet. Share an insight, caveat, or question.
Matsuo et al. (2013) studied Drug-induced QT interval prolongation (n=30). Ciprofloxacin vs. Pre-drug baseline control was evaluated on QT interval and monophasic action potential (MAP90) duration (p=<0.05). Ciprofloxacin at 10 mg/kg significantly prolonged the QT interval (maximum change 11 ms) and monophasic action potential duration in halothane-anesthetized guinea pigs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: